JP2022504707A5 - - Google Patents

Info

Publication number
JP2022504707A5
JP2022504707A5 JP2021519840A JP2021519840A JP2022504707A5 JP 2022504707 A5 JP2022504707 A5 JP 2022504707A5 JP 2021519840 A JP2021519840 A JP 2021519840A JP 2021519840 A JP2021519840 A JP 2021519840A JP 2022504707 A5 JP2022504707 A5 JP 2022504707A5
Authority
JP
Japan
Prior art keywords
group
atoms
double bonds
heteroatoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021519840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/001139 external-priority patent/WO2020074964A1/en
Publication of JP2022504707A publication Critical patent/JP2022504707A/ja
Publication of JP2022504707A5 publication Critical patent/JP2022504707A5/ja
Priority to JP2024073580A priority Critical patent/JP2024122966A/ja
Pending legal-status Critical Current

Links

JP2021519840A 2018-10-11 2019-10-10 芳香族化合物およびその医薬用途 Pending JP2022504707A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024073580A JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862744461P 2018-10-11 2018-10-11
US62/744,461 2018-10-11
PCT/IB2019/001139 WO2020074964A1 (en) 2018-10-11 2019-10-10 Romatic compounds and pharmaceutical uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024073580A Division JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Publications (2)

Publication Number Publication Date
JP2022504707A JP2022504707A (ja) 2022-01-13
JP2022504707A5 true JP2022504707A5 (https=) 2022-10-18

Family

ID=68655570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021519840A Pending JP2022504707A (ja) 2018-10-11 2019-10-10 芳香族化合物およびその医薬用途
JP2024073580A Pending JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024073580A Pending JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Country Status (16)

Country Link
US (1) US12473249B2 (https=)
EP (1) EP3864001A1 (https=)
JP (2) JP2022504707A (https=)
KR (1) KR20210091150A (https=)
CN (2) CN120923343A (https=)
AU (2) AU2019358595B2 (https=)
CA (1) CA3112073A1 (https=)
CL (1) CL2021000846A1 (https=)
CO (1) CO2021006087A2 (https=)
EA (1) EA202190890A1 (https=)
IL (1) IL282134A (https=)
MA (1) MA53188A1 (https=)
MX (1) MX2021003750A (https=)
PH (1) PH12021550744A1 (https=)
SG (1) SG11202103011YA (https=)
WO (1) WO2020074964A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023065200A1 (en) * 2021-10-21 2023-04-27 Givaudan Sa Organic compounds
WO2024206117A1 (en) 2023-03-24 2024-10-03 Northsea Therapeutics B.V. Benzoic acid derivatives for use in methods of treating intestinal failure-associated liver disease in children

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210266A (en) * 1987-12-03 1993-05-11 Dainippon Pharmaceutical Co., Ltd. N-substituted mercaptopropanamide derivatives
ATE155684T1 (de) 1992-04-28 1997-08-15 Fresenius Ag Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
JP5026655B2 (ja) 2001-04-18 2012-09-12 プロメティック、バイオサイエンシーズ、インコーポレーテッド 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
CN101444496B (zh) * 2001-06-12 2011-04-13 维尔斯达医疗公司 用于治疗代谢失调的化合物
AU2003261935A1 (en) * 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
PT1590314E (pt) * 2003-02-06 2015-11-19 Dompã Farmaceutici S P A Ácidos 2-aril-acéticos, seus derivados e composições farmacêuticas que os contêm
ATE419846T1 (de) 2003-02-07 2009-01-15 Prometic Biosciences Inc Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
CN1750758B (zh) * 2003-02-13 2012-06-20 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
PT1648851E (pt) 2003-07-25 2007-05-31 Prometic Biosciences Inc Praparação de sais metálicos de ácidos gordos de cadeia média
UA83509C2 (en) * 2003-10-15 2008-07-25 Оси Фармасьютикалз, Инк. Imidazopyrazines as tyrosine kinase inhibitors
AU2004295091A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors
MX2007002727A (es) 2004-09-03 2008-03-04 Prometic Biosciences Inc Derivados de purinilo sustituidos con actividad inmunomoduladora y quimioprotectora, y su uso solos o con acidos grasos de longitud de cadena media o gliceridos.
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
NZ554176A (en) 2004-10-01 2010-04-30 Prometic Biosciences Inc Medium-chain length fatty alcohols as stimulators of hematopoiesis
EP1836160A1 (en) 2004-12-24 2007-09-26 CTG Pharma S.r.l. Compounds for treating metabolic syndrome
TW200724138A (en) * 2005-03-29 2007-07-01 Sk Corp Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
US20090270470A1 (en) * 2005-05-09 2009-10-29 Astrazeneca Ab Compounds I
GB0522433D0 (en) * 2005-11-03 2005-12-14 Astrazeneca Ab Therapeutic agents
WO2007093364A1 (en) 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
JP5301272B2 (ja) * 2006-07-31 2013-09-25 Meiji Seikaファルマ株式会社 メタロ−β−ラクタマーゼ阻害剤
JP5526018B2 (ja) * 2007-03-21 2014-06-18 エミスフェアー・テクノロジーズ・インク アリルオキシおよびアルキルオキシ安息香酸送達薬剤
AU2008259804B2 (en) * 2007-06-05 2013-04-18 Sanofi-Aventis Substituted benzoylamino-indan-2-carboxylic acids and related compounds
PT2299998T (pt) 2007-11-02 2018-04-02 Prometic Pharma Smt Ltd Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores
CN101903028B (zh) 2007-12-19 2013-06-05 普罗米蒂克生物科学公司 与吉西他滨组合用于治疗胰腺癌的中等链长脂肪酸、盐类及三酸甘油酯
KR20100135793A (ko) * 2008-03-13 2010-12-27 바스프 에스이 이량체 벤질리덴 말로네이트
CA2724023C (en) * 2008-05-13 2014-02-18 Genmedica Therapeutics Sl Salicylate conjugates useful for treating metabolic disorders
JP2012503595A (ja) * 2008-07-28 2012-02-09 シダンスク ユニバーシティ 代謝病の治療用の化合物
EA022445B1 (ru) 2009-05-04 2016-01-29 Прометик Байосайенсиз Инк. Замещенные ароматические соединения, композиции на их основе и их фармацевтические применения
BRPI1015120B8 (pt) * 2009-05-08 2022-02-15 Basf As Composto lipídico alfa-substituídos, derivados de ácidos graxos beta-oxo poli-insaturados, composição farmacêutica e lipídica e métodos para produzir composto lipídico e ácido 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaeniloxi)butanóico
CA2775009A1 (en) * 2009-10-20 2011-04-28 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
LT2641596T (lt) 2009-11-26 2018-08-10 Genfit 1,3-difenilprop-2-en-1-ono darinių panaudojimas kepenų sutrikimų gydymui
TWI572352B (zh) 2012-03-01 2017-03-01 波麥堤克藥學Smt有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
US9562041B2 (en) 2012-05-16 2017-02-07 Glaxosmithkline Llc Enhancer of zeste homolog 2 inhibitors
TWI689490B (zh) 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
WO2015179697A1 (en) * 2014-05-21 2015-11-26 Taxis Pharmaceuticals, Inc. Compounds for the treatment of bacterial infections
KR20170066614A (ko) 2014-10-10 2017-06-14 프로메틱 파마 에스엠티 리미티드 당뇨병의 예방 및 치료를 위한 치환된 방향족 화합물 및 약제학적 조성물
GB2543478A (en) * 2015-09-07 2017-04-26 Manchester Metropolitan Univ Glycomimetics
KR102793841B1 (ko) 2018-05-08 2025-04-11 가부시키가이샤 아데카 화합물, 잠재성 첨가제, 조성물, 경화물, 경화물의 제조 방법 및 조성물의 제조 방법

Similar Documents

Publication Publication Date Title
ES2302825T3 (es) Derivados de acido indano acetico y su uso como agentes farmaceuticos, intermedios, y procedimiento de preparacion.
CN102036946A (zh) 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体
JP2023552699A5 (https=)
TW201039815A (en) Compositions and methods for the treatment of inflammation
EP2951164A1 (en) Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
JP5073708B2 (ja) 細胞損傷及び炎症疾患の治療または予防用薬学組成物
JP2022504707A5 (https=)
JP2023513901A5 (https=)
JP2015522617A (ja) タンパク質凝集の阻害剤としてのジ−およびトリ−ヘテロアリール誘導体
CN102093246A (zh) 酯类化合物、其制备方法和应用
JP5751168B2 (ja) 線維筋痛症の治療剤又は予防剤
KR102628396B1 (ko) 샤프롱-매개 자가포식 조절제로서 유용한 화합물
CN111801013A (zh) 小分子核受体调节剂的酰胺前药
JP2008507498A (ja) アルツハイマー病の治療のためのアリール酢酸および関連化合物
JP2018515463A5 (https=)
JP2021522327A5 (https=)
JP4832897B2 (ja) エステル誘導体及びその医薬用途
JP2024122966A (ja) 芳香族化合物およびその医薬用途
US9527852B2 (en) Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation
JPS61257967A (ja) 2−ピロリドン誘導体
JOP20230072A1 (ar) تحضير مشتقات بنزيميدازولون كمثبطات داي أسيل جليسريد o -أسيل ترانسفيراز 2 جديدة
JP5682555B2 (ja) アルツハイマー病の治療剤又は予防剤
JP2018510206A5 (https=)
WO2012145899A1 (zh) 酯类化合物、其制备方法和应用
CN102190632B (zh) 2,4,5-三取代硒唑类化合物及其制备方法、组合物和用途